Connect with us

Technology

Matic Marks a Year of Momentum: From a Single Ambient Scribe to a 15x-Growth Clinical Intelligence Ecosystem Powering Patients, Practices and Physicians

Published

on

In one year, Matic grew its revenue 15x, cut after-hours charting 83% for physicians, earned a 100% would-buy-again rating from KLAS Research, and evolved from a single ambient scribe into an AI-native ecosystem built around patients, practices and physicians across healthcare.

DALLAS, Aug. 19, 2026 /PRNewswire-PRWeb/ — One year ago, before going into stealth, Matic offered a single product, Scribematic, a best-in-class ambient scribe. Recently, Matic came out of stealth when it launched its AI-native clinical intelligence ecosystem connecting the full care-to-collection lifecycle for patients, physicians, and practices. That progress is backed by independent industry recognition, a marquee partnership with a physician-led primary care network, and revenue growth that reflects accelerating demand across the healthcare system.

Matic now connects panel management, chart preparation, ambient documentation, clinical evidence, medical coding, practice oversight, patient communication, and care coordination into a single ecosystem built around what the company calls the Three P’s: Patients, Practices, and Physicians. The result: patients get the best care, practices get the best economics, and physicians fall back in love with practicing medicine.

Where It Started: One Scribe, One Stubborn Belief

Matic’s story starts with two paths colliding from opposite directions. Dr. Alex Sheppert, DO, PhD, MBA, an AI engineer and published AI researcher, founded Scribematic while in medical school, building one of the world’s first ambient scribes to solve a problem he was living firsthand: the burden of clinical documentation. Calvin Carter spent nearly two decades on the other end of the technology spectrum as founder and CEO of Bottle Rocket, creating award-winning consumer apps for brands like Chick-fil-A, NPR and Southwest Airlines. Rather than simply commercialize what Sheppert built, Carter stepped in as CEO, moved the company to Dallas, and rebuilt it from the ground up around one belief: serve the physician first, and everyone else wins. That partnership, a physician-programmer and a design mind, is why Matic works the way it does. It gives physicians superpowers to deliver the best care of their lives, and takes care of everything else.

In November 2025, the company rebranded from Scribematic to Matic, marking its evolution into a connected platform spanning the entire care-to-collection lifecycle. Codematic, its medical coding and revenue-integrity product, launched the same month, and UrgentIQ, a leading AI-native urgent care EHR, selected Matic Inside to power real-time, in-platform documentation.

Building the Full Ecosystem

What followed was a rapid build-out of what Matic calls ‘The Matics’: a total solution, not a point solution. Every piece, from chart preparation to medical coding, carries forward and builds on itself instead of solving one task in isolation. Patient history informs documentation, documentation informs coding, and evidence informs decisions in one connected system.

The ecosystem today includes:

Scribematic: ambient, multilingual clinical documentationCodematic: clinical-intent medical coding and revenue integritySummatic: longitudinal patient context and continuity across encountersProofmatic: citation-backed clinical evidence with patient context inside the workflowFlowmatic: care-flow coordination across teams and settingsPulsematic: intelligent prioritization of the clinical inbox

Independent Validation

The market has taken notice. In January 2026, KLAS Research named Scribematic an Emerging Company in AI-driven medical documentation, citing accuracy, deep customizability, and a 100% repeat-buy intent among interviewed customers. The following month, Noorda College of Osteopathic Medicine chose Matic to prepare its medical students for AI-enabled clinical practice, a full-circle moment for the platform born in Noorda’s own clinical rotations. Catalyst Health Group selected Matic to deploy across its network of primary care physicians, and UrgentIQ, a leading AI-native urgent care EHR, integrated Matic Inside to power its real-time, in-platform documentation.

Founder and CTO Dr. Alex Sheppert, DO, PhD, MBA, has also become a recognized voice in healthcare AI. In the past year, he’s published peer-reviewed research in the Journal of the American Medical Informatics Association and the International Journal of Medical Informatics on how large language models reason, and sometimes fail, in clinical settings, written for the Forbes Technology Council on AI’s expanding role in the workplace, and delivered invited lectures at Baylor University Medical Center and his alma mater, Noorda College of Osteopathic Medicine. CEO Calvin Carter has drawn similar recognition: he was named to the 2026 AI 75 by Dallas Innovates and the Dallas Regional Chamber, and is a finalist for D CEO’s 2026 Leadership Excellence Award.

Exiting Stealth: The New PX

In June 2026, Matic exited stealth with what it calls the New PX, a fully reimagined Patient, Practice and Physician experience engineered by that same founding pair: Dr. Alex Sheppert, DO, PhD, MBA, the physician-programmer who lived the problem firsthand, and Calvin Carter, founder of Bottle Rocket, whose team built award-winning digital experiences for Chick-fil-A, NPR, Southwest Airlines, LEGO and Starwood/Marriott, work recognized four times in Apple’s App Store Hall of Fame. Carter’s track record has been chronicled by Dallas’ business press: he’s a past winner of Ernst & Young’s Entrepreneur of the Year and Tech Titans’ CEO of the Year, a repeat honoree on D CEO Magazine’s Dallas 500 list, and was named to the 2026 AI 75 by Dallas Innovates and the Dallas Regional Chamber. He’s also a finalist for D CEO’s 2026 Leadership Excellence Award. D CEO and D Magazine have continued to track his move into healthcare, most recently profiling Matic’s mission to bring AI into clinical care.

The New PX is built on three governing principles: start with the stakeholders- physicians, patients, and practices, not the billing system; design for experience, not just function; and win through engagement, not mandates. Every capability inside Matic is designed, tested, and refined inside a live clinical environment rather than shipped as a fixed, generic tool and left for physicians to adapt around.

“Human-centered design is at our core. We reimagined the experience for what we call the Three P’s: patients, practices and physicians. We built, deployed and tested solutions until we were certain we served all three at once.” – Calvin Carter, CEO of Matic

A Declaration for Primary Care

Weeks later, timed to the country’s 250th birthday, Matic and Catalyst Health Group (the physician-led, AI-native primary care network founded by Dr. Christopher Crow, MD, MBA, supporting more than 850+ physicians and advanced practice providers across Texas) issued a joint Declaration of Independence for Primary Care, outlining Ten Fundamental Freedoms for Physicians and sharing the first public results of Matic deployed at scale inside a real physician network. Catalyst physicians reported dramatic reductions in unlocked charts, near-immediate note completion, and a return to the kind of present, human care that drew them to medicine in the first place.

“Primary care has been marginalized or undervalued for a long time, even though we know it’s what helps people live longer, healthier and more meaningful lives. Our job is to put primary care back where it belongs and give physicians the support they need to do what they do best: care for patients. That’s where Matic comes in, using technology to take work off their plate, sharpen their thinking, and bring the human connection back into care.” – Dr. Christopher Crow, MD, CEO of Catalyst Health Group

“When you serve the physician first, everyone benefits. Physicians deliver better care, patients get better outcomes, and practices thrive. Catalyst Health Group has proven that in real clinical use, and we are just getting started.” – Calvin Carter, CEO of Matic

The Numbers Behind the Momentum

This Declaration isn’t just a statement of intent. It’s validated by results. Across the Catalyst physician network, Matic has turned physician burnout, long treated as an unavoidable cost of practicing medicine, into a measurable, moving number:

Speed, per encounter:

60 seconds: physician fully prepared for patient encounter35 seconds: customized coding-aware clinical note from live audio11.2 minutes: average encounter length due to complete prep and reduced administrative tasks. What looks like a faster visit is actually a more attentive one: physicians spend that time examining, listening, and talking with patients instead of reconstructing a chart.Under a minute: nonuple-checked diagnosis and billing codes, returned with the clinical evidence attached.

Scale and reliability:

97%: same-day chart closure rate across tracked encounters99%: ambient documentation accuracy

Physician impact:

Physicians using the platform report approximately 90 minutes of administrative time returned per dayDocumentation accuracy reported at 99% by adopting physicians, generated within seconds of each visitAfter-hours charting down 83% across the Catalyst networkThe ability to see up to 4 more patients each dayReduced revenue leakage and claims appeal costs100% reported loving practicing again, reduced cognitive burden, and increased preparedness for better care

Patient impact:

Care gaps surface before the patient is roomed rather than after the visit endsCare plans arrive complete and evidence-backed, grounded in the patient’s own history rather than a generic protocolFollow-up and inbox messages are handled with full patient context intactPatients report that time with their physician feels different, and that they feel more valued

One physician cleared a 17-chart backlog to fully closed documentation by lunchtime the day after adopting Matic. Physicians across the network describe the same shift: less time buried in a chart, more time with the person in front of them.

“Matic gives me back time and mental space. Instead of starting early, staying late, and digging through data, I can focus on the patient in front of me. It reduces the cognitive load and lets me practice medicine the way I intended.” – Dr. Doug Fullington, Catalyst Physician Group

“With Matic, I now walk into each visit fully prepared. I can focus entirely on the patient, be more thorough, and more present.” – Dr. Madhavi Ampajwala, Catalyst Physician Group

“You press a button and within seconds you have a complete note. The accuracy has been 99.9%, and it’s immediate.” – Dr. Phu Truong, Catalyst Physician Group

“A few months in, I’m seeing nearly twice as many patients and getting more done each day. My patients notice it too. They tell me they feel more attention when we’re together.” – Stephen Buksh, MD, Catalyst Physician Group

“We built Matic because I lived the problem. I know what it feels like to finish notes instead of being with my family, to look at a screen instead of a patient. A year ago we were solving one problem. Today we’re solving the whole system, and the market is telling us, in the fastest way it can, that this is the right problem to solve.” – Alex Sheppert, DO, PhD, MBA, Founder and CTO of Matic

Those outcomes are a big part of why Matic has grown revenue 15x since its founding rebrand, proof that when physicians win, the business does too.

What’s Next

Matic is now available to independent primary care practices, physician groups, ambulatory care organizations, and health systems, fully integrated with existing EHRs including the athenahealth ecosystem, and available to technology partners.

About Matic

Matic gives physicians superpowers and takes care of everything else, so they can deliver the best care of their lives: better outcomes for patients, better economics for practices, and physicians who fall back in love with practicing medicine. Learn more at www.maticinside.ai.

Media Contact

Shaunna Eguilior, Matic, 1 3054988463, shaunna@maticinside.ai, https://maticinside.ai/

View original content:https://www.prweb.com/releases/matic-marks-a-year-of-momentum-from-a-single-ambient-scribe-to-a-15x-growth-clinical-intelligence-ecosystem-powering-patients-practices-and-physicians-302854869.html

SOURCE Matic

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ISASecure to Develop Certification Scheme for Commercial Components Procured by US Government

Published

on

By

DURHAM, N.C., Aug. 20, 2026 /PRNewswire/ — The International Society of Automation (ISA) — the leading professional society for automation — announced that ISASecure®, a wholly owned subsidiary of ISA, is partnering with the United States National Security Agency (NSA) to develop a new certification scheme for commercial operational technology (OT) components sold by manufacturers and procured by the US government for use within National Security Systems (NSS). With a common goal of securing high criticality OT systems, the new certification scheme is intended to increase confidence in the security of commercial components.

ISA developed a set of security levels (SL) with specific cybersecurity requirements for OT components in the international OT cybersecurity standard ISA 62443-4-2. In addition, six new technical security requirements were developed and published by NSA’s Operational Technology Assurance Partnership (OTAP) Program in the NSA/CSS Cybersecurity Technical Report titled “Operational Technology Assurance Partnership: Smart Controller Security within National Security Systems” (April 2025).

In response to the need, ISASecure is developing a separate High Criticality Component Security Assurance (HCSA) certification scheme derived from the well-established Component Security Assurance certification scheme (CSA). Upon completion and the OTAP program office’s acceptance of the ISASecure HCSA scheme, the NSA will use the scheme as an approved certification mechanism in the evaluation process of adding OT OEM components to the NSS OT Product Compliant List (PCL).

“This is a major achievement in the history of ISASecure,” said Dr. Mark P. DeAngelo, program manager of ISASecure. “The NSA recognizes the importance of the ISA 62443 standard and the ISASecure program, which independently evaluates a product’s conformity to the ISA 62443 standard. ISASecure’s reputation and commitment to robust OT security precedes the NSA’s decision to partner with us. Our CSA product certification set the foundation for HCSA.”

An ISASecure HCSA certificate provides a product manufacturer with essential evidence in consideration of that product’s inclusion on the NSA’s NSS OT PCL. In other words, ISASecure certification is an important step before a smart controller can be purchased and installed within an NSS.

Manufacturers interested in developing smart controllers are encouraged to join ISASecure to be part of the HCSA development. Stakeholders include manufacturers of components, accreditation bodies and certification bodies. For more information, contact Dr. Mark P. DeAngelo, program manager, ISASecure at ISASecure@isa.org.

About ISASecure®

Founded in 2007 by the International Society of Automation (ISA), the ISASecure® mission is to provide the highest level of assurance possible for the cybersecurity of industrial automation control systems. ISASecure, a wholly owned subsidiary of ISA, is a globally recognized ISA/IEC 62443 conformance scheme, conducting certifications for off-the-shelf control system products and supplier development practices since 2010.

Founders and key supporters of ISASecure include BP, Chevron, ExxonMobil, Saudi Aramco, Shell, GSK, Honeywell, Johnson Controls, Schneider Electric, Yokogawa, Carrier, Siemens, YPF, Amazon Web Services, exida, TUV Rheinland, CSSC, FM Approvals, Synopsys, Trust CB, SecurityGate, BYHON, TUV SUD, Trane and Bureau Veritas. The program’s ISASecure designation signifies to the marketplace that industrial automation and control products conform to industry-consensus cybersecurity standards. The ISASecure trademark provides confidence to users of ISASecure certified products and systems and creates product differentiation for suppliers who conform to the ISASecure specifications. Learn more at isasecure.org.

About ISA

The International Society of Automation (ISA) is a non-profit professional association founded in 1945 to create a better world through automation. ISA’s mission is to empower the global automation community through standards and knowledge sharing. ISA develops widely used global standards and conformity assessment programs; certifies professionals; provides education and training; publishes books and technical articles; hosts conferences and exhibits; and provides networking and career development programs for its members and customers around the world. Learn more at www.isa.org.

About the OTAP Program

The Operational Technology Assurance Partnership (OTAP) Program provides the US government with a trusted, repeatable and technically rigorous mechanism to assess, validate and assure the cybersecurity of operational technology (OT) components and systems used within National Security Systems (NSS).

Through structured collaboration with US government stakeholders, OEMs and standards bodies, OTAP enables informed acquisition, risk management and deployment decisions that strengthen the resilience and mission assurance of cyber-physical systems critical to national defense and security. Its mission is to ensure NSS mission resilience and cybersecurity by validating the security and compliance of OT and fortify these systems by establishing and verifying rigorous, testable security requirements that enable OT cybersecurity and resilience.

View original content to download multimedia:https://www.prnewswire.com/news-releases/isasecure-to-develop-certification-scheme-for-commercial-components-procured-by-us-government-302856502.html

SOURCE The International Society of Automation

Continue Reading

Technology

“Fundamentals of Radiation Oncology, 4th Edition” Selected for 2026 Doody’s Core Titles in Radiation Oncology

Published

on

By

PANAMA CITY, Fla., Aug. 20, 2026 /PRNewswire/ — Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition, edited by Hasan Murshed, MD, has been selected for the 2026 Doody’s Core Titles in Radiation Oncology, an annual distinction recognizing texts considered essential to the education of trainees and practicing clinicians in the specialty. Doody’s Core Titles is among the most respected collection of  development tools in health sciences publishing, compiled through a rigorous peer review process involving clinicians, educators, and medical librarians to guide collection development for medical libraries, residency programs, and academic institutions.

Published by Elsevier/Academic Press, the fourth edition integrates radiation physics, radiation biology, treatment planning, and clinical oncology into a single accessible volume, including contemporary coverage of artificial intelligence, adaptive radiotherapy, immunotherapy, proton therapy, SRS, SBRT, and advanced IMRT/IGRT techniques.

“We are honored that Fundamentals of Radiation Oncology has been selected for the 2026 Doody’s Core Titles,” said Dr. Murshed. “Radiation oncology is evolving faster than any clinician can track. Our goal was to create a practical, comprehensive, and clinically relevant resource that helps trainees and practicing clinicians keep pace with the field. This recognition reflects the dedication and expertise of our outstanding authors and contributors.”

About Doody’s Core Titles

An annual peer-reviewed resource identifying the most essential texts in healthcare education, widely used by medical libraries, academic institutions, and residency programs to guide acquisition decisions.

About the Book

A comprehensive overview of modern radiation oncology, integrating foundational science with contemporary clinical practice. Written for residents, fellows, practicing radiation oncologists, and multidisciplinary oncology professionals, the text serves as both a board preparation resource and a practical clinical reference.

About the Editor

Hasan Murshed, MD is a radiation oncologist, Medical Director of Hope Regional Cancer Center, and Editor of Fundamentals of Radiation Oncology, 4th Edition.

Media Contact: Hasan Murshed, MD | hmurshedmd@gmail.com | drhasanmurshed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/fundamentals-of-radiation-oncology-4th-edition-selected-for-2026-doodys-core-titles-in-radiation-oncology-302855530.html

SOURCE Hasan Murshed MD, Author

Continue Reading

Technology

TROOPS, Inc. (NASDAQ: TROO) Issues Statement Rebutting Misleading Short-Seller Report and Provides Update on Hong Kong Legal Proceedings

Published

on

By

HONG KONG, Aug. 20, 2026 /PRNewswire/ — TROOPS, Inc. (NASDAQ: TROO) (“TROOPS” or the “Company”) today issued the following statement in response to a short-selling report published by Muddy Insights (https://muddyinsights.com/reports/troo-jul11-2026) (the “Report”) concerning the Company and related legal proceedings in Hong Kong.

The Report contains speculative assertions, selective presentation of facts, and unsubstantiated conclusions regarding the Company’s financial position, legal exposure, and ongoing court matters. Management strongly disagrees with the Report’s characterization of events and its predictions of imminent adverse outcomes. 

As previously disclosed, on June 23, 2025, the High Court of the Hong Kong Special Administrative Region Court of First Instance issued a judgment in Action No. HCA 938/2022 (https://legalref.judiciary.hk/lrs/common/search/search_result_detail_frame.jsp?DIS=169843&QS=%2B%7C%28Hca%2C938%2F2022%29&TP=JU). Among other orders, the Court held that:

–  TROOPS, Inc. and its subsidiaries SGOCO International (HK) Limited and Giant Connection Limited, amongst other defendants, are jointly and severally liable for payment of HK$163,400,000; and

–  The Company and its subsidiary SGOCO International (HK) Limited, amongst other defendants, are jointly and severally liable for payment of HK$241,400,000

The Company and its subsidiaries are only three of eleven jointly and severally liable defendants. This indicates that the Company should be liable to pay only a portion of the judgment sum, given that other defendants are also liable for the judgment and have already provided assets to the court as security under court injunctions.

In addition, the Company filed a Notice of Appeal on July 21, 2025. The Hong Kong Court of Appeal has scheduled the appeal hearing for February 24 – 26, 2027, while the hearing for stay of execution of the judgment took place on May 8, 2026 and the hearing for directions on consequential matters took place on August 20, 2026.

No adverse conclusions have been reached by the Court in these hearings. Stay of execution of the judgment has been granted by the Court and remains in effect until the results of the appeal hearing scheduled for February 2027. As a result, enforcement of the judgment is stayed, and the related Cayman Islands winding-up petition continues to be adjourned in accordance with prior consent orders pending resolution of the Hong Kong appeal process.

These developments directly contradict the Report’s central premise of an imminent “endgame,” winding-up order, or Nasdaq suspension risk arising from the August 20 hearing. The Company’s legal position remains protected by the stay, and management continues to prosecute the appeal vigorously with the goal of overturning or substantially reducing the judgment.

The Report recycles previously disclosed information, adds speculative interpretations about the Company’s resources, trading activity, and ability to fund its defense, and draws conclusions that are neither supported by the record nor consistent with the current status of the proceedings. TROOPS, Inc. remains a going concern, continues to operate its businesses, and is committed to protecting the interests of its shareholders through the appeal and, where appropriate, other legal avenues.

Management reiterates its confidence in the merits of the appeal and its determination to pursue all available remedies. The Company will continue to provide updates on material developments in accordance with its disclosure obligations.

About TROOPS, Inc.

TROOPS, Inc. is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in (a) money lending business in Hong Kong providing mortgage loans to high quality target borrowers, (b) property investment to generate additional rental income and, (c) the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, big data and blockchain, and cloud computing (SaaS), (d) advisory and referral services in relation to the application of migration, education and visa renewal to its customers, and (e) consultancy services for insurance products in respect of insurance referral to insurance brokers. The group’s vision is to operate as a conglomerate to build synergy within its own sustainable ecosystem thereby creating value to its shareholders.

For more information about TROOPS, Inc., please visit our investor relations website: www.troops.co

Safe Harbor and Informational Statement

This announcement contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of the Company set forth herein and those preceded by or that include the words “believe,” “expect,” “anticipate,” “future,” “will,” “intend,” “plan,” “estimate” or similar expressions, are “forward-looking statements”. Forward-looking statements in this release include, without limitation, the effectiveness of the Company’s multiple-brand, multiple channel strategy and the transitioning of its product development and sales focus and to a “light-asset” model, Although the Company’s management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward looking statements involve a number of risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. These forward-looking statements can change as a result of many possible events or factors not all of which are known to the Company, which may include, without limitation, our ability to have effective internal control over financial reporting; our success in designing and distributing products under brands licensed from others; management of sales trend and client mix; possibility of securing loans and other financing without efficient fixed assets as collaterals; changes in government policy in China; China’s overall economic conditions and local market economic conditions; our ability to expand through strategic acquisitions and establishment of new locations; compliance with government regulations; legislation or regulatory environments; geopolitical events, and other events and/or risks outlined in TROOPS’ filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F and other filings. All information provided in this press release and in the attachments is as of the date of the issuance, and TROOPS does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

View original content:https://www.prnewswire.com/news-releases/troops-inc-nasdaq-troo-issues-statement-rebutting-misleading-short-seller-report-and-provides-update-on-hong-kong-legal-proceedings-302856512.html

SOURCE TROOPS

Continue Reading

Trending